Mei-Sze Chua

Molecular profiling of anemia in acute renal allograft rejection using DNA microarrays.

Increased expression of cytotoxic effector molecules: different interpretations for steroid-based and steroid-free immunosuppression.

Microarrays: new tools for transplantation research.

Applications of microarrays to renal transplantation: progress and possibilities.

Gallium maltolate is a promising chemotherapeutic agent for the treatment of hepatocellular carcinoma.

Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma.

N-Myc down-regulated gene 1 mediates proliferation, invasion, and apoptosis of hepatocellular carcinoma cells.

Small interfering RNA targeting CDC25B inhibits liver tumor growth in vitro and in vivo.

Antibody Arrays Identify Potential Diagnostic Markers of Hepatocellular Carcinoma.

Small molecule antagonists of Tcf4/beta-catenin complex inhibit the growth of HCC cells in vitro and in vivo.

Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells.

Rodent-specific hypoxia response elements enhance PAI-1 expression through HIF-1 or HIF-2 in mouse hepatoma cells.

Soluble Frizzled-7 receptor inhibits Wnt signaling and sensitizes hepatocellular carcinoma cells towards doxorubicin.

Suppression of glypican 3 inhibits growth of hepatocellular carcinoma cells through up-regulation of TGF-β2.

Assessment and comparison of magnetic nanoparticles as MRI contrast agents in a rodent model of human hepatocellular carcinoma.

Molecular imaging of hepatocellular carcinoma xenografts with epidermal growth factor receptor targeted affibody probes.

Suppressing N-Myc downstream regulated gene 1 reactivates senescence signaling and inhibits tumor growth in hepatocellular carcinoma.

Epigenetics in hepatocellular carcinoma: an update and future therapy perspectives.

Imaging of hepatocellular carcinoma patient-derived xenografts using ⁸⁹Zr-labeled anti-glypican-3 monoclonal antibody.

Novel celastrol derivatives inhibit the growth of hepatocellular carcinoma patient-derived xenografts.

Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.

NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3β and Nur77 to prevent β-catenin degradation.

Suppression of ATAD2 inhibits hepatocellular carcinoma progression through activation of p53- and p38-mediated apoptotic signaling.

Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling.

5-Hydroxymethylcytosine signatures in cell-free DNA provide information about tumor types and stages.

A transfer-RNA-derived small RNA regulates ribosome biogenesis.

SOCS5 inhibition induces autophagy to impair metastasis in hepatocellular carcinoma cells via the PI3K/Akt/mTOR pathway.

Correction: SOCS5 inhibition induces autophagy to impair metastasis in hepatocellular carcinoma cells via the PI3K/Akt/mTOR pathway.

An Automated, Quantitative, and Multiplexed Assay Suitable for Point-of-Care Hepatitis B Virus Diagnostics.

High Inflammatory Factor Grading Predicts Poor Disease-Free Survival in AJCC Stage I-II Hepatocellular Carcinoma Patients After R0 Resection.

An NIR-II/MR dual modal nanoprobe for liver cancer imaging.

Analysis of Infected Host Gene Expression Reveals Repurposed Drug Candidates and Time-Dependent Host Response Dynamics for COVID-19.

NIR-II imaging of hepatocellular carcinoma based on a humanized anti-GPC3 antibody.